Hepatic syndromes and cytokine indices in patients with hepatic cirrhosis

Cover Page

Cite item

Full Text

Abstract

Aim. To analyze the clinical manifestations of hepatic cirrhosis (HC) of different etiology and their correlation with proinflammatory cytokine level – interleukin-6 and tumor necrosis factor-alpha (TNF-α).

Materials and methods. Fifty patients with viral hepatic cirrhosis (as a result of chronic hepatitis C), 20 patients with alcoholic HC, 16 persons with mixed etiology HC (viral and alcoholic) with the mean age 53 ± 13.01 years were examined. Hepatic cirrhosis was diagnosed using complex data of clinicolaboratory and instrumental studies. The levels of IL-6 and TNF-α were determined with the kits of “VectorBest” company (Russia, Novosibirsk) using the method of enzyme immunoassay and registration of results on photometer “Stat-Fax” 2100 (USA).

Results. No reliable differences in clinical manifestations and cytokine level in HC of different etiology were detected. The levels of cytokine concentration median significantly elevated as HC progressed. Interleukin-6 demonstrated moderate correlations with lethargy and hepatocellular insufficiency as a whole (Ki = 0.673 and Ki = 0.607, respectively).

Conclusions. Clinical syndromes of HC practically do not depend on etiology of disease. Increase in production of IL-6 and TNF-a demonstrates pathogenetic significance of proinflammatory cytokines in the lesion of the liver. IL-6 level correlates with the severity of liver lesion and, thus, objectifies clinical symptoms in HC patients, especially those based on patients’ complaints.

About the authors

A. P. Schekotova

E.A. Vagner Perm State Medical University

Author for correspondence.
Email: al_shchekotova@mail.ru

профессор кафедры факультетской терапии №2, профессиональных болезней и клинической лабораторной диагностики, д.м.н., доцент

Russian Federation, Perm

I. A. Bulatova

E.A. Vagner Perm State Medical University

Email: bula.1977@mail.ru

профессор кафедры факультетской терапии №2, профессиональных болезней и клинической лабораторной диагностики

Russian Federation, Perm

S. V. Paducheva

E.A. Vagner Perm State Medical University

Email: paducheva_sv@mail.ru

соискатель кафедры факультетской терапии №2, профессиональных болезней и клинической лабораторной диагностики

Russian Federation, Perm

References

  1. Бондарева К.С., Лебедев П.В. Клиническая характеристика хронического гепатита и цирроза печени различной этиологии. Кубанский научный медицинский вестник 2013; 5 (140): 46–51.
  2. Булатова И.А., Долгих О.В., Падучева С.В., Щекотова А.П., Шелудько В.С. Способ диагностики степени тяжести цирроза печени смешанной этиологии: патент на изобретение № 2632101 от 02.10.2017 г. по заявке № 2016117613 от 04.05.2016 г. Бюллетень № 28.
  3. Ивашкин В.Т., Маевская М.В., Павлов Ч.С., Федосьина Е.А., Бессонова Е.Н., Пирогова И.Ю., Гарбузенко Д.В. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 2016; 4 (26): 71–100.
  4. Павлов А.И., Хазанов А.И. Лабораторная диагностика интоксикации алкоголем у лиц с алкогольной болезнью печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 2010; 1: 41–51.
  5. Fast facts about liver disease: Europeian Association for the Study of the Liver. 2016, available at: www.2016.ilc-congress.eu/wp/ -content/uploads/2016/04/Liver-disease-back-grounder.pdf.
  6. Management of alcohol-related liver diseases: Clinical Practice Guidelines. J Hepatol 2018; 69: 154–181.
  7. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology 2015; 63: 237–264.
  8. Dirchwolf М., Ruf А. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. J Hepatol 2015; 8: 1974–1981.
  9. PrystupaА., KicińskiР., Sak J., Boguszewska-Czubara A., Toruń-Jurkowska A., Załuska W. Proinflammatory cytokines (IL-1α, IL-6) and hepatocyte growth factor in patients with alcohol-lic liver cirrhosis. Gastroenterol Res Pract 2015; 532615.

Copyright (c) 2019 Schekotova A.P., Bulatova I.A., Paducheva S.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies